| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |